The 5th CMC-China China International Biological & Chemical Pharmaceutical Expo 2023, hosted by Pharma Fusion Circle, Pharmacy Zongheng and Synbio Shenbo, co-organized by Junda Hechuang and supported by Shenzhen Hua Sol, was grandly opened at Suzhou International Expo Center. FarmaSino Co., Ltd. was invited to participate in the exhibition, comprehensively displaying the six core businesses, consolidating the existing cooperative relationship, exploring potential customers, and laying the foundation for opening up the market.

Meeting background

The 5th CMC-China China International Bio & Chemical Pharmaceutical Expo 2023 will have three venues, including Innovation Source Power Hall (Hall C1), Preparation Brand Hall (Hall D1), and Raw and Auxiliary Package Hall (Hall E1). The conference involves cell and gene therapy, antibody drugs, small molecule innovative drugs, generic drugs, MAH B certificate, improved new drugs, APIs, synthetic biology, green pharmaceuticals, and preparation CRO and CDMO cooperation.

The conference joined hands with nearly 1,000 upstream and downstream high-quality biopharmaceutical enterprises to hold 25 forums, inviting more than 300 speakers, bringing together medical experts, pharmaceutical enterprises and pharmaceutical colleagues in various fields such as government, industry, academia, research, finance, and media. The scene was full of talents, full of seats, and lively.

Booth style

FarmaSino Co., Ltd.'s booth attracted countless exhibitors and had warm communication with our staff. The staff always greets every exhibitor with full enthusiasm and patience. In order to let the professional visitors and exhibitors have a certain understanding of Kaiyuan Pharmaceutical, the staff gave a vivid speech on the company's product characteristics and advantages. The audience and enterprises at the venue have great interest in our exhibited products and cooperation models, and many customers have conducted detailed consultations on the spot, hoping that the company will have in-depth cooperation through this opportunity.

Special event

At this meeting, Yan Libo, Chairman of FarmaSino Co., Ltd., participated in the 4th China API Entrepreneurs Annual Conference, showing the overview and excellent achievements of Kaiyuan Pharmaceutical, so that everyone can have a deeper understanding of Kaiyuan Pharmaceutical. At this annual meeting of entrepreneurs, many industry experts and entrepreneurs gathered together for sharing and exchange meetings. The atmosphere at the meeting was very high, and I hope that the company will have more partners through this sharing.

FarmaSino Co., Ltd. is a member of Jiangsu Huihong International Group, one of the top 500 enterprises in China, mainly engaged in the international trade of pharmaceutical-related products, and its products are sold in more than 100 countries and regions around the world, and is the vice president unit of the China Chamber of Commerce for Import and Export of Medicines and Health Products. With high quality, excellent service and good brand, the company has won a broader development space, and has a high reputation and good reputation in the field of international and domestic medicine and health.

FarmaSino Co., Ltd. is a wholly-owned core subsidiary of Kaiyuan Pharmaceutical, providing one-stop technical services for the R&D and registration of generic drugs and innovative drugs, and has established industry-university-research cooperation with many universities and scientific research units such as China Pharmaceutical University and Nanjing University of Chinese Medicine. In 2021, the company obtained the B certificate of "Drug Manufacturing License" as a marketing authorization holder (MAH). The company has won the national "high-tech enterprise" certification, CNAS laboratory accreditation, national intellectual property management system certification, established Jiangsu Province enterprise graduate workstation, and won the honorary titles of Jiangsu Top 100 Science and Technology Service Institutions, Nanjing Engineering Technology Research Center for Consistency Evaluation of Generic Drugs, Nanjing Engineering Research Center, Nanjing Credit Management Demonstration Enterprise and so on.

1. Generic drug research and development registration technical services
2. New drug creation and technical services
3. Drug MAH cooperation and transfer
4. One-time import of reference preparations
5. Customized synthesis of pharmaceutical intermediates
6. International registration and sales of drugs